Algea Therapies
Country not established
- Devices
- 1
What Algea Therapies makes
Algea Therapies manufactures the AFFIRM™ VCF System, a device designed for the treatment of vertebral compression fractures (VCFs). This system is intended to provide structural support and stabilization to affected vertebrae, aiding in pain relief and spinal alignment.
The AFFIRM™ VCF System is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Affirm (Tm) Vcf System Ref K110998
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Algea Therapies have in the registry?
The registry currently lists 1 device for Algea Therapies. Devices recorded under merged duplicate company entries are counted once.
Which registries list Algea Therapies's devices?
Among its 1 most recently registered device, Algea Therapies has devices listed in FDA 510(k) (1 device).
What risk classes do Algea Therapies's devices fall under?
Among its 1 most recently registered device, the classes recorded for Algea Therapies's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Algea Therapies in the registry?
The most recently registered devices listed for Algea Therapies include AFFIRM (TM) VCF SYSTEM.